financetom
Business
financetom
/
Business
/
Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program
Jun 26, 2024 7:06 AM

09:35 AM EDT, 06/26/2024 (MT Newswires) -- Oramed Pharmaceuticals ( ORMP ) said Wednesday that its board approved a share-buyback program of up to $20 million.

The program is effective over a 12-month period and will be funded with existing cash, the company said.

Price: 2.41, Change: +0.17, Percent Change: +7.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mueller Industries Subsidiary Plans $7 Million Investment to Expand Arkansas Operations
Mueller Industries Subsidiary Plans $7 Million Investment to Expand Arkansas Operations
Jul 15, 2025
05:05 PM EDT, 07/15/2025 (MT Newswires) -- Mueller Industries' ( MLI ) subsidiary, Mueller Streamline, plans to invest more than $7 million to expand its manufacturing facility in Wynne, Arkansas, adding 60 new jobs over the next two years. The initiative aims to expand distribution and packaging operations, the company said Tuesday in a statement. ...
Kezar Says US FDA Lifts Partial Clinical Hold on Zetomipzomib Trial in Autoimmune Hepatitis; Shares Rise After Hours
Kezar Says US FDA Lifts Partial Clinical Hold on Zetomipzomib Trial in Autoimmune Hepatitis; Shares Rise After Hours
Jul 15, 2025
05:05 PM EDT, 07/15/2025 (MT Newswires) -- Kezar Life Sciences ( KZR ) said Tuesday that the US Food and Drug Administration's Division of Hepatology and Nutrition has lifted the partial clinical hold on the completed phase 2a trial assessing zetomipzomib in people with autoimmune hepatitis (AIH). Kezar said it also plans to respond to the FDA's Division of Rheumatology...
US auto safety nominee calls for active oversight of self-driving cars
US auto safety nominee calls for active oversight of self-driving cars
Jul 15, 2025
WASHINGTON, July 15 (Reuters) - President Donald Trump's nominee to head the nation's auto safety regulator will argue on Wednesday that the agency must actively oversee self-driving vehicle technology, a potential sign of a tougher approach than some critics expected. Jonathan Morrison, chief counsel of the National Highway Traffic Safety Administration in the first Trump administration, will testify to the...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved